receptors (D 1 and D5) that couple to the Gs protein and "D2-like" receptors (D 2, D3, and D4) that couple to Gi. Although inhaled dopamine has been reported to induce bronchodilation in patients with asthma, functional expression of dopamine receptor subtypes has never been described on airway smooth muscle (ASM) cells. Acute activation of G i-coupled receptors inhibits adenylyl cyclase activity and cAMP synthesis, which classically impairs ASM relaxation. In contrast, chronic activation of G i-coupled receptors produces a paradoxical enhancement of adenylyl cyclase activity referred to as heterologous sensitization. We questioned whether the dopamine D 2-like receptor is expressed on ASM, whether it exhibits classical G icoupling, and whether it modulates ASM function. We detected the mRNA encoding the dopamine D 2 receptor in total RNA isolated from native human ASM and from cultured human airway smooth muscle (HASM) cells. Immunoblots identified the dopamine D 2 receptor protein in both native human and guinea pig ASM and cultured HASM cells. The dopamine D 2 receptor protein was immunohistochemically localized to both human and guinea pig ASM. Acute activation of the dopamine D 2 receptor by quinpirole inhibited forskolin-stimulated adenylyl cyclase activity in HASM cells, which was blocked by the dopamine D 2 receptor antagonist L-741626. In contrast, the chronic pretreatment (1 h) with quinpirole potentiated forskolin-stimulated adenylyl cyclase activity, which was inhibited by L-741626, the phospholipase C inhibitor U73122, or the protein kinase C inhibitor GF109203X. Quinpirole also stimulated inositol phosphate synthesis, which was inhibited by L-741626 or U73122. Chronic pretreatment (1 h) of the guinea pig tracheal rings with quinpirole significantly potentiated forskolin-induced airway relaxation, which was inhibited by L-741626. These results demonstrate that functional dopamine D 2 receptors are expressed on ASM and could be a novel therapeutic target for the relaxation of ASM. reverse transcriptase polymerase chain reaction; immunoblot; guinea pig; organ bath DOPAMINE IS AN ENDOGENOUS catecholamine that influences many cellular activities, including behavior, hormone synthesis and release, blood pressure, and intracellular ion transport. The dopamine receptor is a member of the superfamily of heptahelical G-protein-coupled receptors that have been divided into two subgroups, "D 1 -like" receptors (D 1 and D 5 ) that couple to the G s protein and "D 2 -like" receptors (D 2 , D 3 , and D 4 ) that couple to G i (27, 29) .
helical G-protein-coupled receptors that have been divided into two subgroups, "D 1 -like" receptors (D 1 and D 5 ) that couple to the G s protein and "D 2 -like" receptors (D 2 , D 3 , and D 4 ) that couple to G i (27, 29) .
In patients with asthma, inhalation of dopamine has a bronchodilatory effect during bronchial obstruction (10, 12, 26) . Although the dopamine D 2 -like receptor has been identified in the dorsal root ganglia and airway projecting sensory neurons (33, 34) , the functional expression of this receptor has never been described on airway smooth muscle cells.
The stimulation of G i -coupled receptors leads to inhibition of adenylyl cyclase activity and a consequent reduction in cellular cAMP levels (9) , which classically impairs airway smooth muscle relaxation (38) . However, when the G i -coupled receptors are chronically activated, there is a paradoxical and perhaps compensatory enhancement of adenylyl cyclase activity, which is called heterologous sensitization (48) . This sensitization has been demonstrated following the persistent activation of a number of G i -coupled receptors, including dopamine D 2 and D 4 , A 3 adenosine, ␣ 2 -adrenergic, and -opioid receptors (3, 22, 31, 46, 48) .
In the present study, we provide evidence that the dopamine D 2 -like receptor is expressed in native human and guinea pig airway smooth muscle and cultured human airway smooth muscle (HASM) cells, exhibits classical G i -coupling, and following chronic stimulation induces airway smooth muscle relaxation.
METHODS
Materials. HASM cells were cultured in M-199 smooth muscle medium containing human fibroblast growth factor, human epidermal growth factor, FBS, and antibiotic-antimycotic which were purchased from Invitrogen (Grand Island, NY). Lysates of human brain cerebral cortex were used as a positive protein control on immunoblots and were obtained from BD Biosciences (Palo Alto, CA). Total RNA from whole human brain was purchased from Clontech (Mountain View, CA). Pertussis toxin (PTX) and protease inhibitor cocktail III was purchased from EMD Biosciences (San Diego, CA). ␣-[
32 P]ATP (800 Ci/mmol), [ 3 H]cAMP (32 Ci/mmol), and [ 3 H]myo-inositol (20 Ci/ mmol) were obtained from MP Biomedicals (Irvine, CA). Quinpirole, L-741626, and U73122 were purchased from Tocris Bioscience (Ellisville, MO). All other chemicals were obtained from Sigma (St. Louis, MO) unless otherwise stated.
Cell culture. Primary cultures of HASM cells came from two sources. Cells were obtained from Lonza (Walkersville, MD) or at the University of Pennsylvania, which were obtained from lung transplant donors in accordance with procedures approved by the University of Pennsylvania Committee on Studies Involving Human Beings as previously described (32) . Cells were grown in culture medium [M-199 , supplemented with 10% FBS, 1 ng/ml human fibroblast growth factor, 250 pg/ml human epidermal growth factor, and an antibiotic-antimycotic mix (100 U/ml penicillin G sodium, 100 g/ml streptomycin sulfate, and 0.25 g/ml amphotericin B)] at 37°C in a humidified atmosphere of 5% CO 2-95% air. For immunoblotting, cells were grown to confluency in T75 flasks. Cells were rinsed with cold PBS and scraped in cold PBS. Cells were pelleted (500 g, 10 min, 4°C) and lysed in cold lysis buffer (50 mM Tris·HCl pH 8.0, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 150 mM NaCl, 1 mM EDTA, 1:200 dilution of protease inhibitor cocktail III, 1 mM Na 3VO4, and 1 mM NaF). Lysed cells were centrifuged (15,000 g, 15 min, 4°C), and an aliquot of the supernatant was subjected to protein analysis before solubilizing the samples by heating at 95°C for 5 min in sample buffer (final concentrations: 50 mM Tris·HCl pH 6.8, 2.5% SDS, 6% glycerol, 2.5% 2-mercaptoethanol, and bromophenol blue) and storing at Ϫ20°C.
Isolation of smooth muscle from human trachea and guinea pig for RNA and protein analysis. All studies were approved by the Columbia University's Institutional Review Board and deemed not human subjects research under 45 CFR 46. All animal studies were approved by the Columbia University Institutional Animal Care and Use Committee. These studies were also reviewed by the Committee on the Ethics of Animal Experiments in Tohoku University School of Medicine, and they were carried out in accordance with both the Guidelines for Animal Experiments issued by the Tohoku University and The Law (No. 105) and Notification (No. 6) issued by the Japanese Government.
Human trachea came from two sources. Snap frozen tracheas obtained at autopsy from nonasthmatic adults within 8 h of death were obtained from the National Disease Research Exchange (NDRI, Philadelphia, PA). Additional trachea were obtained from discarded regions of healthy donor lungs harvested for lung transplantation at Columbia University. Lung transplant excess tissue was transported to the laboratory on ice and submerged in cold (4°C) Krebs-Henseleit (KH) buffer (in mM: 118 NaCl, 5.6 KCl, 0.5 CaCl 2, 0.24 MgSO4, 1.3 NaH2PO4, 25 NaHCO3, and 5.6 glucose pH 7.4).
Adult male guinea pigs were deeply anesthetized by intraperitoneal pentobarbital (50 mg/kg), the chest cavity was opened, and the animal exsanguinated before dissection of the trachea. The trachea or whole brain were surgically removed and placed in cold (4°C) KH buffer.
The exteriors of either the human or guinea pig trachea were meticulously dissected free of adherent connective tissue under a dissecting microscope. Tracheas were opened longitudinally along the anterior border, the epithelium was removed, and the airway smooth muscle between the noncontiguous ends of the cartilaginous tracheal rings was dissected free. Airway smooth muscle or whole brain was homogenized (Tekmar Ultra Turrax T25 high-speed homogenizer set at top speed for 30 s) in Trizol reagent (Ambion, Austin, TX) for total RNA extraction according to the manufacturer's recommendations or in cold (4°C) buffer (50 mM Tris, 10 mM HEPES pH 7.4, and 1 mM EDTA with a 1:200 dilution of protease inhibitor cocktail III) for total protein isolation. The homogenate was filtered through 125-m Nitex mesh and centrifuged twice at 500 g for 15 min. The supernatant was transferred into new tubes and centrifuged at 50,000 g for 30 min at 4°C. The final membrane pellet was resuspended in the same buffer for protein concentration determinations and stored at Ϫ80°C.
RNA isolation and RT-PCR. Total RNA was extracted from freshly dissected native human or guinea pig airway smooth muscle, cultured HASM cells, and guinea pig whole brain using Trizol Reagent (Ambion, Austin, TX) according to the manufacturer's recommendations. Total RNA from whole human brain (Clontech, Mountain View, CA) was used as a positive control. With the use of the Advantage RT-for-PCR kit (Clontech), 1 g of total RNA was reverse transcribed at 42°C for 1 h in 20 l including 200 U of Moloney murine leukemia virus reverse transcriptase, 20 U of RNase inhibitor, 20 pmol oligo (dT) primer, and 0.5 mM each of dNTP mix in reaction buffer (50 mM Tris·HCl pH 8.3, 75 mM KCl, and 3 mM MgCl 2).
PCR was performed by addition of 5 l of newly synthesized cDNA to a 45 l reaction mixture yielding final concentrations of 0.2 mM of each dNTP, 1ϫ Advantage 2 polymerase mix, PCR buffer (Clontech), and 0.4 M of both sense and antisense primers for the D 2 subgroup (D2, D3, and D4) of dopamine receptors (Table 1) . Two-step PCR (annealing and extension at same temperature) was performed for 1 min with a PTC-200 Peltier thermal cycler (MJ Research) for all PCR reactions, and all reactions included an initial denaturation step at 94°C for 1 min followed by 40 cycles of denaturation (94°C for 10 s) and annealing/extension at 72°C for 1 min. PCR products were electrophoresed on 5% nondenaturing polyacrylamide gels in 1ϫ Tris, acetate, EDTA buffer. The gel was stained with ethidium bromide (Molecular Probes, Eugene, OR), visualized using ultraviolet illumination, and analyzed using Quantity One software (Bio-Rad, Hercules, CA).
Western blot analysis. Membrane lysates were electrophoresed (8% SDS-PAGE) and transferred to PVDF membranes. The PVDF membranes were blocked for 1 h at room temperature with 5% membrane blocking agent (RPN2125V; GE Healthcare, Arlington Heights, IL) in TBS with 0.1% Tween 20 and were then probed with antibodies directed against the dopamine D 2 receptor protein (rabbit polyclonal 1:1,000; AB5084P; Millipore, Seattle, WA) overnight at 4°C. After being washed three times, membranes were incubated for 1 h at room temperature with horseradish peroxidase-conjugated secondary antirabbit antibodies (1:5,000; NA931V; GE Healthcare). The signals from the immunoreactive bands were detected by ECL Plus (GE Healthcare) according to the manufacturer's recommendations and the signal was captured by luminescent image analyzer (LAS-1,000; Fujifilm, Tokyo, Japan).
Immunohistochemistry. Human tracheal rings were fixed with 4% paraformaldehyde/1% glutaraldehyde in 0.1 M phosphate buffer for 4 h at 4°C. Guinea pig tracheal rings were fixed with 4% paraformaldehyde in 0.1 M phosphate buffer for 24 h at 4°C. Tracheal rings were paraffin embedded, sectioned (10 m), dewaxed in xylene, and rehydrated in a graded alcohol series to water. Heat-mediated antigen retrieval was performed with Tris-EDTA buffer (10 mM Tris base and 1 mM EDTA pH 9.0) for 2 min using a pressure cooker. Endogenous peroxidase was blocked using 3% hydrogen peroxide for 15 min at room temperature. Sections were blocked with 10% normal serum for 30 min. After being washed with PBS with 0.1% Triton X-100 (PBST), an avidin biotin blocking kit (Vector Laboratories, Peterborough, UK) was used (in 10% serum in PBS) to block endogenous Human dopamine D2 FP: 5=-GGA CCT CCC TCA AGA CCA TGA GCC GTA-3= 287 RP: 5=-GCA GCA GAG TCA GCA GTG GAG GAT CTT CAG-3= Human dopamine D3 FP: 5=-GAG TCC CAC CAT AGC GCC CAA GCT CAG-3= 241 RP: 5=-ACT GTA AAG CTC TGG GGA CAC GTG GCA-3= Human dopamine D4 FP: 5=-GCT CTC CTG GTG CTG CCG CTC TTC GTC TAC T-3= 168 RP :5=-CAC GGC CAC GGC CAC GAA CCT GT-3= FR, forward primer; RP, reverse primer. biotin. Slides were rinsed with PBST and incubated overnight at 4°C in primary antibody against dopamine D2 receptor protein (for human tracheal ring sections: rabbit polyclonal 1:2,000; HPA015691; Sigma; for guinea pig tracheal ring sections: rabbit polyclonal 1:2,000; AB5084P; Millipore) in 2% normal goat serum in PBST or against ␣-smooth muscle actin (mouse monoclonal 1:10,000; MAB1522; Millipore) in 2% normal horse serum in PBST. A tracheal ring section was incubated with the appropriate isotype IgG (rabbit IgG or mouse IgG2a) antibody as a negative control. Following overnight incubation at 4°C, slides were washed three times with PBST and primary antibodies were detected using biotinylated anti-rabbit or anti-mouse antibodies (Vector Laboratories, Peterborough, UK) at a concentration of 1:100. After incubation with the ABC-horseradish peroxidase complex (Vector Laboratories, Peterborough, UK) for 30 min, the antigen antibody complex was then visualized with the peroxidase substrate kit (DAB; SK-4100; Vector Laboratories). Sections were counterstained with hematoxylin (Vector Laboratories), dried, dehydrated in a graded alcohol series and xylene, and coverslipped using Poly-mount (Polysciences, Warrington, PA).
Adenylyl cyclase assays. Adenylyl cyclase activity was measured as previously described (19) . Briefly, HASM cells in 24-well plates were washed once with warm PBS (37°C). In some experiments, the cells were pretreated for 4 h with PTX (100 ng/ml) or for 30 min with L-741626 (1 M) in cell culture medium before being washed with PBS. In acute experiments, 100 l of warm PBS were added to each well. Subsequently, 50 l of 3ϫ adenylyl cyclase buffer (19) were added directly to the wells [to achieve final concentrations of 50 mM HEPES pH 8.0, 50 mM NaCl, 0.4 mM EGTA, 1 mM cAMP, 7 mM MgCl2, 0.1 mM ATP (20 Ci/ml 32 P-␣-ATP), 0.1 mg/ml BSA, 50 U/ml creatine phosphokinase, and 7 mM phosphocreatine] in the absence (basal activity) or presence of 10 For all experiments, the reactions were terminated by the addition of 100 l stop buffer [50 mM HEPES pH 7.5, 2 mM ATP, 0.5 mM cAMP (0.5 Ci/ml 3 H-cAMP), and 2% SDS] and synthesized 32 PcAMP was separated and quantitated by sequentially column chromatography over dowex and alumina as described previously (37) .
Inositol phosphate assays. Synthesis of total [ 3 H]inositol phosphates was measured in confluent HASM cells in 24-well tissue culture plates as described previously (19, 23) . Briefly, after overnight loading with 3 H-myo-inositol (10 Ci/ml, 20 Ci/mmol) in inositolfree and serum-free DMEM (Chemicon, Temecula, CA), plates were washed three times (37°C, 500 l HBSS with 10 mM LiCl). Incubation of cells with quinpirole (1 M) in a final volume of 300 l (HBSS with 10mM LiCl) at 37°C for 30 min was performed in the absence or presence of PTX (100 ng/ml; 4 h before the addition of quinpirole), U73122 (5 M; 30 min before the addition of quinpirole), or L-741626 (1 M; 30 min before the addition of quinpirole). Incubation of the cells with L-741626 (1 M) alone in a final volume of 300 l at 37°C for 30 min was also performed to determine whether L-741626 by itself exerts any effect on inositol phosphate synthesis. Reactions were terminated, and total [
3 H]inositol phosphates were recovered by column chromatography (19) .
In vitro effects of chronic treatment with dopamine D 2 receptor agonist on guinea pig airway smooth muscle relaxation. All studies were approved by the Columbia University's Institutional Animal Care and Use Committee. Force measurements were performed on closed guinea pig tracheal rings suspended in organ baths as previously described (23) . Briefly, Hartley male guinea pigs (ϳ400 g body wt) were anesthetized with 50 mg/kg ip pentobarbital, the tracheas were removed promptly and dissected into closed rings comprised of two cartilagenous rings from which mucosa, connective tissue, and epithelium were removed. Silk threads were tied to the rings such that the threads were at each end of the posterior aspect of the ring (lacking in cartilage), ϳ180°from one another. One thread was attached to a fixed point at the bottom of 4-ml organ baths (Radnoti Glass Technology, Monrovia, CA), and the opposing thread was attached to a Grass FT03 force transducer (Grass-Telefactor, West Warwick, RI) coupled to a computer via Biopac hardware and Acknowledge 7.3.3 software (Biopac Systems, Goleta, CA) for continuous digital recording of muscle tension. The rings were suspended in 4 ml of KH buffer solution (composition in mM: 118 NaCl, 5.6 KCl, 0.5 CaCl 2, 0.2 MgSO4, 25 NaHCO3, 1.3 NaH2PO4, and 5.6 D-glucose) with 10 M indomethacin (DMSO vehicle final concentration of 0.01%), which was continuously bubbled with 95% O2-5% CO2 at pH 7.4, 37°C. The rings were equilibrated at 1 g of isotonic tension for 1 h with new KH buffer added every 15 min. All rings were precontracted with two cycles of cumulatively increasing concentration of acetylcholine (0.1 M-1 mM) with extensive buffer washes between and after these two cycles with resetting of the resting tension to 1. Statistical analysis. Statistical analysis was performed using repeated-measures ANOVA, followed by Bonferroni posttest comparison using GraphPad Instat 3.0.6 software (GraphPad Software, San Diego, CA). Data are presented as means Ϯ SE. P Ͻ 0.05 was considered significant. (Fig. 1) . Messenger RNA encoding the dopamine D 3 and D 4 receptors was not detected in freshly dissected airway smooth muscle from human upper airways despite their detection in control human brain RNA. In primary cultures of HASM cells, mRNA encoding the dopamine D 2 and D 4 receptors was detected whereas D 3 was not detected (Fig. 1) .
RESULTS

RT-PCR analysis of dopamine
Immunoblot analysis of dopamine D 2 -like receptors in airway smooth muscle. Lysates prepared from freshly dissected native HASM, freshly dissected native guinea pig airway smooth muscle and cultured HASM cells were subjected to immunoblot analysis using a specific antidopamine D 2 receptor antibody (Fig. 2) . Immunoreactive bands of appropriate molecular mass of ϳ50 kDa for dopamine D 2 receptor were identified airway smooth muscle from all three sources. The antibody used to detect the dopamine D 2 receptor protein is capable of identifying two isoforms of the dopamine D 2 receptor (D 2 L and D 2 S). The higher band of the appropriate molecular mass for dopamine D 2 L (50.6 kDa) was identified in primary cultures of HASM cells and in freshly isolated airway smooth muscle from guinea pig, while the D 2 S (47.4 kDa) was identified in freshly isolated airway smooth muscle from human and guinea pig (Fig. 2) .
Immunohistochemical detection of dopamine D 2 receptor expression in guinea pig airway smooth muscle. To confirm the localization of dopamine D 2 receptor protein to airway smooth muscle, immunohistochemistry was performed using a rabbit polyclonal antibody that recognizes the dopamine D 2 receptor proteins in paraffin sections of both human and guinea pig tracheal rings. Specific immunoreactivity was detected in the airway smooth muscle layer of both human and guinea pig trachea (indicated by brown color) with no staining in the negative control sections using an isotype-specific rabbit IgG or mouse IgG2a control primary antibodies. In addition, no specific immunoreactivity was detected in the airway epithelial layer of both human and guinea pig trachea (Fig. 3) .
Agonist-induced adenylyl cyclase activity in HASM cells.
Dopamine D 2 receptor-mediated acute inhibition and chronic activation of adenylyl cyclase activity via the G i protein are well known in neurons (48) . To examine whether a dopamine D 2 receptor agonist has similar effects on adenylyl cyclase activities in cultured HASM cells, we measured adenylyl cyclase activity in the presence or absence of the dopamine D 2 receptor agonist quinpirole. Acute activation of the dopamine D 2 receptor with quinpirole (1 M) significantly inhibited the forskolin-stimulated adenylyl cyclase activity (P Ͻ 0.01; n ϭ 13), which was significantly blocked by pretreatment with the G i inhibitor PTX (100 ng/ml; 4 h; P Ͻ 0.05, n ϭ 13) or the dopamine D 2 receptor antagonist L-741626 (1 M; P Ͻ 0.05; n ϭ 13; Fig. 4A ). In contrast, chronic pretreatment with the same drugs resulted in a heterologous sensitization of adenylyl cyclase activity. The chronic (1 h) pretreatment with quinpirole (1 M) significantly enhanced the forskolin-stimulated adenylyl cyclase activity (P Ͻ 0.001; n ϭ 14), which was significantly blocked by the selective dopamine D 2 receptor antagonist L-741626 (1 M; P Ͻ 0.05; n ϭ 14) in a PTX (100 ng/ml; 4 h)-insensitive manner (NS; n ϭ 14; Fig. 4B ). In addition, as shown in Fig. 5 , this sensitization of adenylyl cyclase activity by chronic activation of the dopamine D 2 receptor with quinpirole was significantly blocked by either the PLC inhibitor U73122 (5 M; P Ͻ 0.05; n ϭ 8; Fig. 5A ) or the PKC inhibitor GF109203X (100 nM; P Ͻ 0.05; n ϭ 9; Fig. 5B) .
Agonist-induced stimulation of inositol phosphate synthesis in HASM cells. Classically receptors that couple to the G q protein activate PLC increasing inositol phosphates and intracellular calcium. Similarly, in G i -coupled receptors, cross-talk to PLC␤ 1 from liberated G i ␣ or G i ␤␥ subunits has been described in other cell types (1, 14, 16, 42) . To examine whether the dopamine D 2 receptor agonist stimulate inositol phosphate synthesis in cultured HASM cells, we measured the quinpirole-induced inositol phosphate synthesis in the presence or absence of L-741626, U73122, or PTX. Quinpirole (1 M) significantly increased inositol phos- Representative immunoblot analyses using antibodies against the dopamine D2 receptor using protein prepared from cultured HASM cells (100 g), freshly dissected native human tracheal airway smooth muscle (SM; 100 g), and freshly dissected native guinea pig (GP) tracheal SM (100 g) identifying two known isoforms of the dopamine D2 receptor (D2L and D2S). White spaces between the 3 lanes indicate that these lanes were located on the same immunoblot but were not located in neighbouring lanes on the original gel and immunoblot image.
phate synthesis (P Ͻ 0.05; n ϭ 8), which was significantly blocked by L-741626 (P Ͻ 0.05; n ϭ 8; 1 M; Fig. 6A ). Pretreatment the cells with U73122 (5 M; 30 min) also significantly blocked the quinpirole-induced inositol phosphate synthesis, whereas the pretreatment with PTX (100 ng/ml; 4 h) did not significantly block quinpirole-induced synthesis of inositol phosphates (NS; n ϭ 5; Fig. 6B ).
Functional studies of dopamine D 2 receptor function in intact guinea pig airway rings. Molecular identification of multiple subunits of dopamine D 2 receptors led us to question 
DISCUSSION
The primary findings of the present study include the first demonstration of dopamine D 2 receptor mRNA and protein expression in human and guinea pig airway smooth muscle cells and the ability of a dopamine D 2 receptor-selective agonist to facilitate the relaxation against acetylcholine-induced contraction in airway smooth muscle through adenylyl cyclase sensitization.
The dopamine D 2 -like receptor is ubiquitously expressed in the central nervous system, and the modulation of neuronal activity by dopamine has been extensively studied. Numerous studies (17, 18, 20, 25, 28, 40) have also indicated the expression of functional dopamine D 2 receptors in peripheral and nonneuronal cells such as pulmonary artery (36), renal tubules, glomeruli (postganglionic sympathetic nerve terminals), and zona glomerulosa cells of the adrenal cortex.
Identification of mRNA in freshly isolated HASM ensures that native expression of the dopamine D 2 -like receptor (D 2 , D 3 , and D 4 ) is being identified. However, even with careful dissection freshly isolated tissue is contaminated by other cells types that could give rise to cDNA products during sensitive RT-PCR amplification. Therefore, we also evaluated the expression of the dopamine D 2 -like receptor in established primary cultures of HASM cells, which are a homogenous population of airway smooth muscle cells. Despite their cellular purity, cultured cell systems can result in an altered phenotype of protein expression during culture. Despite these limitations, there was remarkable agreement but some differences between the expression of dopamine D 2 -like receptor in freshly isolated vs. cultured HASM. We detected mRNA encoding the dopamine D 2 receptor in dual sources of HASM studied including human freshly isolated airway smooth muscle and cultured HASM cells. In contrast, the dopamine D 4 receptor was not identified in freshly isolated HASM but was readily detected in cultured HASM cells. This (15) , the present study is the first to demonstrate the protein expression of dopamine D 2 receptor localized to airway smooth muscle.
After demonstrating the mRNA and protein expression of dopamine D 2 receptor in airway smooth muscle, we sought to assess its bronchodilatatory effect. Numerous studies have demonstrated that the acute activation of G i -coupled receptors inhibits adenylyl cyclase activity, whereas chronic activation of these inhibitory receptors results in a compensatory increase in cAMP accumulation (47) . Consistent with these previous findings (48), our findings also suggest that acute activation of dopamine D 2 receptor on HASM cells inhibited the adenylyl cyclase activity by a PTX-sensitive pathway, while chronic activation of dopamine D 2 receptor stimulated adenylyl cyclase activity but not via a G i pathway.
This heterologous sensitization of adenylyl cyclase represents an adaptive response to persistent activation of several G i -coupled receptors including dopamine D 2 and D 4 , -opioid, ␦-opioid, ␣ 2 -adrenergic, M 2 and M 4 muscarinic, CB 1 cannabinoid, and 5HT 1A serotonin receptors (2-5, 7, 22, 30, 31, 39, 41, 43, 44, 48) . Although long-term (18 h) agonist pretreatment has been reported to sensitize the adenylyl cyclase activity, short-term agonist pretreatment (2 h) still caused sensitization (48) and was apparent after 20 -30 min of agonist treatments (24) . The sensitization of adenylyl cyclase has also been described in HASM cells (7, 8) . Previous studies (7) have showed that the chronic activation of the G i -coupled receptors with their agonist induced adenylyl cyclase sensitization in HASM cells in PKC-insensitive, PTX-sensitive manner, suggesting that this sensitization is G i -protein mediated. However, in the present study, adenylyl cyclase sensitization induced by chronic activation of the dopamine D 2 receptor on HASM cells was not attenuated by PTX, while both a PLC inhibitor and a PKC inhibitor significantly blocked this sensitization. In addition, activation of the dopamine D 2 receptor stimulated inositol phosphate synthesis in a PLC-sensitive manner. Classically G q -coupled receptors are known to stimulate inositol phosphate synthesis through PLC. However, evidence exists in multiple cell types that activated G i ␣ or G i ␤␥ subunits released from G i -coupled receptor can also cross-activate PLC, which is located downstream of the G q -coupled receptor pathway (1, 14, 16, 42) . PLC promotes the hydrolysis of phosphoinositol 4,5-bisphosphate into inositol phosphates and 1,2-diacylglycerol, which promotes the translocation of PKC from cytoplasm to the membrane and its subsequent activation. Rashid et al. (35) stated that dopamine D 2 receptor stimulates PLC via a cross-talk mechanism through G i ␣ or G i ␤␥ subunits released from the dopamine D 2 receptor. However, this cross-talk mechanism is inconsistent with our findings in that both the adenylyl cyclase sensitization induced by chronic activation of the dopamine D 2 receptor and inositol phosphate synthesis induced by activation of this receptor were not attenuated by PTX, indicating that dopamine D 2 receptor agonist has promiscuous effects on G protein coupling. There is increasing evidence that the dopamine D 2 receptor is capable of forming a heterodimer with the dopamine D 1 receptor and acts as a G q -coupled receptor (35) . Yan et al. (49) also suggested that the dopamine D 2 receptor that classically couples to G i can couple to the G q /PLC␤ pathway, causing an elevation of intracellular Ca 2ϩ and activation of PKC. In our studies, the dopamine D 1 receptor as well as the D 2 receptor protein is expressed in airway smooth muscle (data not shown), suggesting that sensitization of the adenylyl cyclase through G q pathway may be triggered through dopamine D 1 -D 2 receptor heterodimerization. However, detailed mechanisms of this in airway smooth muscle cells have not been investigated.
PKC is involved in the mechanism of heterologous sensitization of adenylyl cyclase isoform VI after activation of G i -coupled receptors (21, 45, 47) . For example, in Chinese hamster ovary cells, prolonged ␦-opioid receptor activation sensitizes subsequent stimulation of adenylyl cyclase isoform VI phosphorylation, and PKC attenuated the sensitization of cAMP response (43, 44) . In contrast, in HEK293 cells expressing both recombinant adenylyl cyclase VI and the dopamine D 2 L receptor, a PKC inhibitor did not attenuate adenylyl cyclase VI sensitization after persistent D 2 L receptor activation (6) . These findings indicate that the mechanism of adenylyl cyclase sensitization differ between cell types. The present study indicated that, in HASM cells, adenylyl cyclase sensitization are mediated via PKC. The purpose of such adenylyl cyclase sensitization in HASM cells is unclear but may involve the need to maintain cAMP synthesis in the face of persistent G i -coupled receptor activation.
In cases of bronchoconstriction, the administration of dopamine, systemically or topically, has a bronchodilatory effect (11, 12, 26) . In the present study, chronic pretreatment of the guinea pig tracheal rings with a dopamine D 2 receptor agonist potentiated forskolin-induced airway relaxation. These findings suggest that the continuous use of a dopamine D 2 receptor agonist with a stimulator of adenylyl cyclase such as a G s -coupled receptor agonist (i.e., ␤ 2 adrenergic receptor agonist) would cooperatively relax the airway smooth muscle through sensitization of adenylyl cyclase activity.
In summary, we demonstrate for the first time the molecular expression of the dopamine D 2 receptor in human and guinea pig airway smooth muscle. We demonstrate that a selective dopamine D 2 receptor agonist can potentiate the relaxation of intact airway smooth muscle contracted with acetylcholine. These studies suggest that dopamine D 2 receptor on airway smooth muscle would be a novel pharmacologic target for the relaxation of airway smooth muscle.
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